-- U.S. RESEARCH ROUNDUP-Twitter, Amgen, Madison Square Garden  
-- 
-- Tue Oct 28, 2014 02:02AM EDT
-- None



Oct 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amgen and Twitter, on Tuesday.

HIGHLIGHTS * Twitter Inc <TWTR.N>: Canaccord Genuity cuts price target to $56 from $62 * Amgen <AMGN.O>: RBC, Jefferies raise price target on the stock * Insulet Corp <PODD.O>: Wedbush starts with outperform rating * Madison Square Garden <MSG.O>: ISI Group raises to buy from hold  Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.   * Allergan <AGN.N>: Sterne Agee raises price target to $215; rating buy * Amgen <AMGN.O>: RBC raises price target to $165 from $150; rating outperform * Amgen <AMGN.O>: Jefferies raises price target to $172 from $142; rating buy * Artisan Partners Asset Management <APAM.N>: RBC cuts target to $62 from $69; outperform * Cavium Inc <CAVM.O>: Jefferies cuts price target to $60 from $64; rating buy * Ducommun Inc <DCO.N>: Canaccord Genuity cuts price target to $28 from $30; rating hold * Insulet Corp <PODD.O>: Wedbush starts with outperform rating; price target $46 * IPC The Hospitalist Co <IPCM.O>: Jefferies cuts price target to $45 from $48; hold * Kohl's Corp <KSS.N>: Deutsche Bank cuts price target to $52 from $55; rating hold * Kohl's Corp <KSS.N>: JP Morgan cuts price target to $50 from $55; rating neutral * Madison Square Garden <MSG.O>: ISI Group raises to buy from hold; target to $74 from $66 * Micron Technology <MU.O>: RBC raises price target to $42 from $41; rating outperform * Silicon Motion <SIMO.O>: B. Riley raises target price to $34.25 from $32 ; rating buy * Tandem Diabetes Care <TNDM.O>: Wedbush starts with outperform rating; price target $20 * Twitter Inc <TWTR.N>: Canaccord Genuity cuts price target to $56 from $62; rating buy * Universal Health Services <UHS.N>: Mizuho raises price target to $120 from $115; buy